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1 The effect of viral infection on the function of neuronal M2 muscarinic autoreceptors in the lungs was
studied in anaesthetized guinea-pigs.
2 Guinea-pigs were inoculated intranasally with either parainfluenza type 3 or with a vehicle control.
Four days later the animals were anaesthetized, paralysed and artificially ventilated. Pulmonary inflation
pressure, tidal volume, blood pressure, and heart rate were recorded. Both vagus nerves were cut and
electrical stimulation of the distal portions caused bronchoconstriction (measured as an increase in pul-
monary inflation pressure) and bradycardia.
3 In control animals, pilocarpine (1-l00,ugkg- , i.v.) attenuated vagally-induced bronchoconstriction by
stimulating inhibitory M2 muscarinic receptors on parasympathetic nerves in the lungs. Conversely,
blockade of these receptors with the antagonist gallamine (0.1-10 mgkg- 1, i.v.) produced a marked poten-
tiation ofvagally-induced bronchoconstriction. These results confirm previous findings.
4 In guinea-pigs infected with parainfluenza virus, pilocarpine did not inhibit vagally-induced broncho-
constriction. Furthermore, gallamine did not potentiate vagally-induced bronchoconstriction to the same
degree as in uninfected controls.
5 There was no increase in baseline pulmonary inflation pressure in the infected animals over the con-
trols. Receptors on airway smooth muscle were unchanged by viral infection since large doses of pilocar-
pine caused equivalent bronchoconstriction in both groups of animals. Gallamine inhibited the
vagally-induced fall in heart rate equally in both groups of animals indicating that virus-induced changes
in M2 receptor function on pulmonary parasympathetic nerves are not part of a generalized decrease in
M2 receptor function.
6 These results demonstrate that the M2 muscarinic receptor-mediated inhibition of acetylcholine
release from parasympathetic nerves in the lungs is decreased in animals infected with parainfluenza virus.
Loss of this inhibition would result in increased release of acetylcholine from the parasympathetic nerves
and may explain virus-induced airway hyperresponsiveness.
Introduction
Viral infections of the lung exacerbate asthma in children and
in adults (Frick et al., 1979; Henderson et al., 1979; Welliver,
1983; Little et al., 1978). In normal subjects viral infection of
the lung produces temporary increases in baseline airways
resistance (Johanson et al., 1969; Picken et al., 1972; Blair et
al., 1976; Hall et al., 1976) and increases bronchial reactivity
to a variety of stimuli (Aquilina et al., 1980; Empey et al.,
1976; Little et al., 1978). These changes often persist for weeks
beyond the period ofclinical illness.
The mechanisms by which viruses induce airway hyper-
responsiveness are poorly understood. There is no evidence
that viral infection causes abnormalities in airway smooth
muscle function. Contraction ofairway smooth muscle in vitro
to muscarinic agonists and histamine has been reported to be
unaltered by viral infection (Buckner et al., 1981; 1985; Jacoby
et al., 1988). In vivo, the bronchoconstrictor response to aero-
solized acetylcholine (ACh) is the same in guinea-pigs infected
with parainfluenza virus as in sham-infected animals (Dusser
et al., 1989).
Virus-induced hyperresponsiveness may be the result of a
defect in the parasympathetic nervous system. In normal sub-
jects, bronchoconstriction induced by exercise or by inhala-
tion of histamine or cold air was temporarily potentiated
during and immediately after respiratory viral infections
(Empey et al., 1976; Aquilina et al., 1980). Both of these
1 Author for correspondence.
responses were blocked by atropine indicating potentiation of
a vagal reflex. A defect in the efferent limb of the parasym-
pathetic nervous system was suggested by Buckner et al.
(1985) who demonstrated that bronchoconstriction induced
by electrical stimulation of the vagus nerves was potentiated
in virus-infected guinea-pigs.
In the airways, release of ACh is under the local control of
muscarinic receptors on postganglionic, parasympathetic
nerves (Fryer & Maclagan, 1984; 1987a,b; Blaber et al., 1985;
Faulkner et al., 1986). Under physiological conditions these
autoreceptors inhibit ACh release, thereby limiting vagally-
induced bronchoconstriction. Blockade ofthese receptors with
selective antagonists such as gallamine potentiates vagally-
mediated bronchoconstriction as much as 10 fold. Therefore,
it is possible that loss of these neuronal receptors may con-
tribute to virus-induced hyperresponsiveness. These experi-
ments were carried out to determine whether virus infection
alters the function of inhibitory muscarinic receptors on the
pulmonary parasympathetic nerves.
Methods
Virus infection
Parainfluenza type 3 (ATCC VR-93) was grown in Rhesus
monkey kidney cell monolayers in L-15 medium for one week
at 34°C. Cells and medium were frozen and thawed, cleared
by low-speed centrifugation, and stored in aliquots at -70°C.
Specific antigen-free guinea-pigs were anaesthetized with
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methohexitone (20mgkg- , i.p.). Animals in the infected
group were inoculated intranasally with 1ml virus solution
that contained 10i TCID50ml1l (0I times the concentration
required to produce infection in 50% of Rhesus monkey
kidney monolayers), obtained by diluting the viral stock in
Dulbecco's phosphate-buffered saline. Animals in the unin-
fected (control) group were inoculated intranasally with fluids
obtained from virus-free Rhesus monkey kidney cells that
were prepared and diluted in phosphate-buffered saline in the
same way as the viral solutions. Control and infected animals
were housed in separate laminar flow rooms.
Virus isolation and titration
After physiological studies were completed, the guinea-pig
lungs were removed and stored at -70'C. Frozen samples
were thawed, weighed, and homogenized in 2ml phosphate-
buffered saline (Polytron, Brinkman, Lucerne, Switzerland).
Virus was eluted from the tissue homogenate by incubation at
34WC for 1 h. The suspensions were centrifuged at 400g for
30min, and the supernatants were inoculated in serial 10 fold
dilutions into fresh Rhesus monkey kidney cell monolayers.
After one week's incubation at 34WC, the monolayers were
washed and the medium was replaced with a 0.5% suspension
of guinea-pig erythrocytes. After 1 h, the erythrocytes were
washed off, and the monolayers were examined under an
inverted phase-contrast microscope (Olympus) for evidence of
haemadsorption (sticking oferythrocytes to the surface ofcells
expressing the viral hemagglutinin on their surfaces)
(Shelokov et al., 1958). Only data from virus-exposed guinea-
pigs with proven parainfluenza infections are reported.
Anaesthesia
Guinea-pigs (Dunkin Hartley; 250-350g) were used four days
after inoculation with virus or with control media. They were
anaesthetized with urethane (1.5gkg-') injected intraperito-
neally. This dose of urethane produces a deep anaesthesia
lasting 8-10h (Green, 1982). None of the experiments
described lasted for longer than 3h and depth of anaesthesia
was monitored by observing for fluctuations in heart rate and
blood pressure. Guinea-pigs were handled in accordance with
the standards established by the U.S.A. Animal Welfare Acts
set forth in National Institute of Health guidelines and the
Policy and Procedures Manual published by the Johns
Hopkins University School of Hygiene and Public Health
Animal Care and Use Committee.
Measurement ofpulmonary inflation pressure (Ppi)
Once the guinea-pigs were anaesthetized, a carotid artery was
cannulated for measurement ofblood pressure and heart rate.
Cannulae were placed into bothjugular veins for the adminis-
tration of drugs. Both vagi were cut and the distal portions
placed on shielded platinum electrodes immersed in a pool of
liquid paraffin. The animal's body temperature was main-
tained at 37°C with a heating blanket.
The animals were paralysed with suxamethonium (infused
at lOupgkg-1 min-1) and ventilated with a positive pressure,
constant volume animal ventilator (Harvard). Airflow was
recorded as the pressure drop across a Fleisch pneumotacho-
graph (3/0) measured with a Grass differential pressure trans-
ducer (PT5B). The airflow signal was integrated to give tidal
volume. Pulmonary inflation pressure (Ppi) was measured
with a Spectromed pressure transducer (DTX). All signals
were displayed on a Grass polygraph. Po2 and Pco2 were
measured in arterial blood samples at the beginning and end
ofeach experiment (Corning 170pH/blood gas analyser).
A positive pressure of 85-100mmH20 was needed for ade-
quate ventilation of the animals. Bronchoconstriction was
measured as the increase in Ppi over the basal inflation pres-
sure produced by the ventilator (Dixon & Brodie, 1903). The
sensitivity of the method was increased by a baseline sub-
tractor device (University of Maryland, Dept. of Biophysics)
which cut offthe basal inflation pressure allowing the increase
in Ppi to be recorded at a greater amplification on a separate
channel of the polygraph (Burden & Parkes, 1971). With this
method, increases in pressure as small as 2-3mmH2O could
be recorded accurately. Changes in pulmonary inflation pres-
sure reflect changes in resistance and compliance ofthe lungs.
Simultaneous stimulation of both vagus nerves (2-15Hz,
0.2ms, 5-30V), produced a bronchoconstriction and a fall in
heart rate. The nerves were stimulated regularly at 2min inter-
vals and the number of pulses per train were kept constant for
each set ofexperiments. All animals were pretreated with gua-
nethidine 5mgkg-1, i.v. This dose of guanethidine has been
demonstrated to deplete noradrenaline and it produced a tem-
porary reduction in the magnitude of the vagally-induced
bronchoconstriction and bradycardia. Thirty minutes after
guanethidine, when the responses to stimulation of the vagus
nerves were back to pre-guanethidine values and were repro-
ducible, cumulative dose-response curves measuring the effect
of pilocarpine or gallamine on vagally-induced broncho-
constriction were performed. Doses of pilocarpine greater
than 30.ugkg-' produced a transient bronchoconstriction.
Therefore, the effect of these doses of pilocarpine on vagally-
induced bronchoconstriction was measured after the Ppi had
returned to baseline. At the end of each experiment vagally-
induced bronchoconstriction and bradycardia were abolished
by atropine (1mgkg-1, i.v.) indicating that both of these
responses were mediated via release of ACh onto muscarinic
receptors.
Drugs
Gallamine, pilocarpine, suxamethonium, atropine, and ure-
thane were purchased from Sigma, St. Louis, MO, U.S.A.;
guanethidine was supplied by CIBA, Summit, NJ, U.S.A.; and
methohexitone was purchased from Eli Lilly, Indianapolis,
IN, U.S.A. All drugs were dissolved and diluted in 0.9% NaCl
solution. Rhesus monkey kidney cells were purchased from
Viromed, Minnetonka, MN, U.S.A.
Statistics
The effects of viral infection on dose-response curves to pilo-
carpine and gallamine were compared by two-way analysis of
variance. The initial responses to stimulation of the vagus
nerves were compared between control and infected guinea-
pigs by unpaired Student's t tests. A P value less than 0.05 was
considered significant.
Results
All virus-exposed animals became infected with the virus.
Homogenates of lungs from virus-exposed guinea-pigs con-
tained 104-7 + 100.22 TCID50/100mg tissue weight (geometric
mean + s.e.mean). Lungs from control guinea-pigs contained
no titratable virus.
There was no difference in baseline Ppi (85-l00mmH20) or
baseline heart rate (280-320 beatsmin-1) between control and
virus-infected guinea-pigs. Electrical stimulation of the vagus
nerves caused bronchoconstriction (measured as an increase
in Ppi) and bradycardia in both groups. There were no differ-
ences between control and infected guinea-pigs in these
responses (see histograms in Figures 1, 3 and 4).
In control guinea-pigs, stimulation of M2 muscarinic recep-
tors on the parasympathetic nerves by pilocarpine inhibited
vagally-induced bronchoconstriction in dose-dependent
fashion. The degree of inhibition was also dependent on the
frequency of electrical stimulation. Pilocarpine was somewhat
more effective in inhibiting bronchoconstriction elicited at
2Hz compared with 15Hz (Figure la-c, open squares).
In guinea-pigs infected with parainfluenza virus, pilocarpine
was not an effective inhibitor of vagally-induced broncho-PARAINFLUENZA VIRUS DAMAGES PULMONARY M2 RECEPTORS
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constriction. At 2Hz, only the highest dose of pilocarpine
(lOOugkg-') inhibited vagally-induced bronchoconstriction
(Figure la), while at 5 and 15 Hz no dose of pilocarpine was
able to inhibit vagally-induced bronchoconstriction in virus-
infected guinea-pigs (Figure ib,c). Doses greater than
lOOpgkg-' pilocarpine were not used because they caused
sustained bronchoconstriction via stimulation of muscarinic
receptors on the airway smooth muscle.
In both control and infected guinea-pigs, pilocarpine caused
a transient bronchoconstriction (at 30-100 ugkg- 1) and fall in
heart rate (at 1-lOOpugkg-') by stimulating muscarinic recep-
tors on airway smooth muscle and cardiac muscle. There were
no differences in these responses between the control and
infected animals (Figure 2).
In control animals gallamine (O.1-lOmgkg-1) potentiated
vagally-induced bronchoconstriction in a dose-dependent
fashion. In guinea-pigs infected with parainfluenza virus this
potentiation was attenuated, and the dose-response curve
shifted approximately one log unit to the right (Figure 3). In
the heart, gallamine inhibited vagally-induced bradycardia to
the same extent in both control and virus-infected animals
(Figure 4).
Discussion
In control guinea-pigs, pilocarpine inhibited and gallamine
potentiated bronchoconstriction elicited by electrical stimu-
lation of the vagus nerves. These effects are due to stimulation
(pilocarpine) and blockade (gallamine) of inhibitory M2
muscarinic receptors on the pulmonary parasympathetic
Figure 1 Pilocarpine (1-lOOpgkg-', i.v.) does not inhibit vagally-
induced bronchoconstriction in virus-infected guinea-pigs (U) but
does inhibit bronchoconstriction in control animals (a). The effect at
different frequencies of stimulation of the vagus nerves are shown:
2Hz (a), 5Hz (b), and 15Hz (c). The bronchoconstriction in response
to electrical stimulation of the vagus nerves (0.2ms, 5-30V, 75 pulses
per train) in the absence of pilocarpine is shown on the left as an
increase in pulmonary inflation pressure (Ppi) in mmH20 (control,
open column; virus-infected, hatched column). Although the initial
responses were matched, the bronchoconstriction at 2Hz and 5Hz in
infected animals was significantly greater than in control (2Hz,
P = 0.05; 5Hz, P = 0.02; 15Hz, P = 0.12). Results are expressed as
the ratio of vagally-induced bronchoconstriction in the presence of
pilocarpine to the response ofvagal stimulation in the absence ofpilo-
carpine. Each point is the mean of 5 animals with s.e.mean shown by
vertical bars. In control animals, at all three frequencies, pilocarpine
caused a significant, dose-related, inhibition of vagally-induced bron-
choconstriction (P = 0.0001 at all three frequencies). There was also a
significant difference between pilocarpine dose-reponse curves in sham
vs infected guinea-pigs at 2Hz (P = 0.02) and at 5Hz (P = 0.03), but
only a trend at 15Hz (P = 0.25).
nerves (Fryer & Maclagan, 1984; 1987a,b; Blaber et al., 1985;
Faulkner et al., 1986).
Both pilocarpine-induced inhibition and gallamine-induced
potentiation of vagally-mediated bronchoconstriction were
markedly decreased in guinea-pigs infected with parainfluenza
virus. Thus the neuronal M2 receptors cannot be stimulated
by exogenous agonists since pilocarpine did not inhibit
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Figure 2 Pilocarpine (1-l00pgkg-',i.v.) causes a similar degree of
bronchoconstriction (a) measured as an increase in pulmonary infla-
tion pressure (Ppi) and bradycardia (b) measured as a fall in heart rate
in control (El) and virus-infected (U) guinea-pigs. Each point is the
mean of S animals with s.e.mean shown by vertical bars.
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Figure 3 Potentiation of vagally-induced bronchoconstriction by
gallamine (0.1-10mg kg-1, i.v.) is attenuated in guinea-pigs which are
infected with parainfluenza virus (U) compared to control guinea-pigs
(El) (b). The bronchoconstriction in response to electrical stimulation
of the vagus nerves (0.2ms, 15Hz, 5-30V, 75 pulses per train) in the
absence ofgallamine is shown in (a) as an increase in pulmonary infla-
tion pressure (Ppi) in mmH20 (control, open column; virus-infected,
hatched column; there was no significant difference between these
responses, P = 0.29). Results are expressed as the ratio ofthe response
to vagal stimulation in the presence of gallamine to the response to
vagal stimulation in the absence of gallamine. Each point is the mean
of 5 animals with s.e.mean shown by vertical bars. In control animals,
gallamine caused a significant, dose-related, potentiation of vagally-
induced bronchoconstriction (P = 0.0001). There was also a signifi-
cant difference between gallamine dose-response curves in sham vs
infected guinea-pigs (P = 0.013).
vagally-induced bronchoconstriction. Neither can these recep-
tors be stimulated by endogenous ACh, since if ACh were
stimulating these autoreceptors blockade by gallamine would
have potentiated vagally-induced bronchoconstriction.
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Figure 4 Gallamine (0.1-l0mgkg- , i.v.) causes a similar degree of
inhibition of vagally-induced bradycardia in control (El) and virus-
infected (U) guinea-pigs (b). Bradycardia elicited by electrical stimu-
lation of the vagus nerves (0.2ms, 15Hz, 5-30V, 75 pulses per train)
was measured. The bradycardia in response to vagal stimulation in
the absence of gallamine is shown in (a) as a fall in heart rate in beats
min- (control, open column; virus-infected, hatched column; there
was no statistical difference between these responses, P = 0.34).
Results are expressed as the ratio of the response to vagal stimulation
in the presence of gallamine to the response to vagal stimulation in
the absence of gallamine. Each point is the mean of 5 animals with
s.e.mean shown by vertical bars.
Damage to neuronal M2 receptors would be expected to
increase the baseline bronchoconstrictor response to vagal
stimulation in virus-infected animals. Buckner et al. (1985)
demonstrated such an increase in guinea-pigs infected with
parainfluenza virus type 3. In our study, we found a great deal
of variability in the response to electrical stimulation of the
vagus nerves, which we attribute to variation in the isolation
and preparation of the vagus nerves. A different voltage (range
5-30V) was selected, and kept constant throughout each
experiment in order that the initial bronchoconstrictor
responses were similar between sham-infected and virus infect-
ed guinea-pigs. Because the voltages were varied between
experiments the results of Buckner et al. (1985) were not
directly confirmed. However, there was a trend (although not
statistically significant) indicating that a given broncho-
constriction was reached with less voltage in virus-infected
animals (11.0 + 2.8V) than in sham-infected animals
(18.2 + S.OV).
The function of neuronal muscarinic receptors is dependent
upon the frequency at which the vagus nerve is stimulated
(Fryer & Maclagan, 1984). These receptors function best, and
the effects ofantagonists at these receptors are most apparent,
when the nerves are stimulated at higher frequencies (5-
15 Hz). Conversely it is easier to demonstrate the effect of
exogenous agonists when the nerve is firing at lower fre-
quencies. We have confirmed that pilocarpine is a more effec-
tive agonist at 2Hz in control guinea-pigs (Figure 2). In
virus-infected animals we tested whether the effect of pilocar-
pine was inhibited at a range of frequencies because the vagus
nerves in the lung fire normally at 12-15 Hz (Mitchell et al.,
1987).
The changes in the effects of gallamine and pilocarpine on
vagally-induced bronchoconstriction cannot be accounted for
by alterations in resistance since baseline Ppi was the same in
both infected and control animals. Neither of these effects is
related to changes in muscarinic receptors on airway smooth
muscle since the pilocarpine-induced bronchoconstriction was
identical in control and virus-infected animals (see Figure 2a).
Parainfluenza virus primarily infects the airway epithelium
and does not usually spread to infect tissues outside the lungs.
Therefore, M2 receptors in other organs, such as the heart,
should be unchanged by viral infection of the lungs. That
virus-induced changes in M2 receptors in the lung are not part
of a generalized decrease in M2 receptor function was demon-
strated since bradycardia (mediated by M2 muscarinic recep-
tors, Hammer et al., 1986) in response to both vagal
stimulation (Figure 4a) and pilocarpine (Figure 2b) was not
altered from control. Furthermore, gallamine was equally
potent in inhibiting vagally-induced bradycardia in control
and virus-infected animals (Figure 4).
Viral infection increases vagally-mediated reflex broncho-
constriction in guinea-pigs (Buckner et al., 1985) and humans
(Empey et al., 1986; Aquilina et al., 1980). The mechanism for
this potentiation is unclear. Since bronchoconstriction in
response to stimulation of the vagus nerves was potentiated in
guinea-pigs infected with parainfluenza virus (Buckner et al.,
1985) it appears that at least part of this potentiation results
from a defect in the efferent limb of the reflex. Damage to the
inhibitory M2 muscarinic receptors on the pulmonary vagus
nerves, as we have demonstrated, may explain this increase in
vagally-induced bronchoconstriction.
The mechanism of these changes in M2 muscarinic receptor
function in the airways of virus-infected guinea-pigs is
unknown. We have recently shown that exposure of mem-
brane preparations of guinea-pig lungs to parainfluenza virus
in vitro decreases the affinity of agonists for a portion of the
muscarinic receptors (Fryer et al., 1990). This effect is due to
viral neuraminidase, as it can be mimicked by an equivalent
concentration of purified neuramidinase and blocked by a
neuraminidase inhibitor. Because exposure to parainfluenza
virus in vitro caused a similar decrease in agonist affinity for
all of the muscarinic receptors in a membrane preparation of
guinea-pig heart, which contains only M2 receptors, it is pos-
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sible that viral neuraminidase is decreasing agonist affinity
selectively for M2 receptors in the lung. This is consistent with
the fact that M2 muscarinic receptors contain a large number
of sialic acid residues (Peterson et al., 1986) which would be
susceptible to cleavage by neuraminidase and that the sialic
acid residues are involved in agonist binding to M2 receptors
(Gies & Landry, 1988).
M2 muscarinic receptors on parasympathetic nerves in the
lungs normally function to inhibit release of ACh from para-
sympathetic nerves in the lungs. Blockade of these autorecep-
tors removes the negative feedback control they provide,
resulting in a potentiation of vagally-induced broncho-
constriction. The data presented here demonstrate that in
guinea-pigs infected with parainfluenza virus, inhibition of
ACh release by neuronal M2 muscarinic receptors in the lungs
is decreased. Loss of this inhibitory control would result in
potentiation of any vagally-mediated bronchoconstriction,
including reflex bronchoconstriction. It is possible that virus-
induced airway hyperresponsiveness is the result of viral
damage to neural M2 muscarinic receptors in the lungs.
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